MAR 17, 2015 08:43 AM PDT

Mass Spec and Microscopy Image Fusion

WRITTEN BY: Judy O'Rourke
Vanderbilt University researchers have achieved the first "image fusion" of mass spectrometry and microscopy - a technical tour de force that could, among other things, dramatically improve the diagnosis and treatment of cancer.

Microscopy can yield high-resolution images of tissues, but "it really doesn't give you molecular information," says Richard Caprioli, PhD, senior author of the paper recently published in the journal Nature Methods.
Image of a section of the brain shows the fusion of microscopy (pink area) and mass spectrometry (pixelated colors at bottom) to produce a detailed
Mass spectrometry provides a very precise accounting of the proteins, lipids, and other molecules in a given tissue, but in a spatially coarse or pixelated manner. Combining the best features of both imaging modalities allows scientists to see the molecular make-up of tissues in high resolution.

"That to me is just phenomenal," says Caprioli, the Stanford Moore Professor of Biochemistry and director of the Mass Spectrometry Research Center.

Caprioli says the technique could redefine the surgical "margin," the line between cancer cells and normal cells where the scalpel goes to remove the tumor.

Currently that line is determined by histology - the appearance of cells examined under the microscope. But many cancers recur after surgery. That could be because what appear to be normal cells, when analyzed for their protein content using mass spectrometry, are actually cancer cells in the making.

"The application of image fusion approaches to the analysis of tissue sections by microscopy and mass spectrometry is a significant innovation that should change the way that these techniques are used together," says Douglas Sheeley, ScD, senior scientific officer in the National Institute of General Medical Sciences (NIGMS).

"It is an important step in the process of making mass spectrometry data accessible and truly useful for clinicians," he says.

The image fusion project was led by Raf Van de Plas, PhD, a research assistant professor of biochemistry who also has a faculty position at Delft University of Technology in the Netherlands.

Using a mathematical approach called regression analysis, the researchers mapped each pixel of mass spectrometry data onto the corresponding spot on the microscopy image to produce a new, "predicted" image.

It's similar in concept to the line drawn between experimentally determined points in a standard curve, Caprioli says. There are no "real" points between those that were actually measured, yet the line is predicted by the previous experiments.

In the same way, "we're predicting what the data should look like," he says.

[Source: Vanderbilt University]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
JUL 10, 2018
Cancer
JUL 10, 2018
New Potential Inhibitor Target for Mantle Cell Lymphoma
A new small molecule inhibitor, called PTC596, initiated apoptosis in MCL cells according to a study published this month in Oncotarget....
AUG 07, 2018
Cancer
AUG 07, 2018
Potential Bcl-2 Targeted Therapy for Relapsed Multiple Myeloma Patients
Targeted therapy for Bcl-2 may be helpful in more than the two lymphoma diagnoses that were recently approved by the FDA....
AUG 13, 2018
Videos
AUG 13, 2018
What does sunscreen look like with a UV camera?
  Have you ever wondered if there’s really a difference between SPF 30 and SPF 50? You’re not the only one. YouTuber Physics Girl set out...
AUG 14, 2018
Cancer
AUG 14, 2018
New Drug for Refractory Cutaneous T-cell Lymphoma
Mogamulizumab was approved by the FDA this month after a very successful Phase III clinical trial demonstrating its effectiveness in treating patients with challenging CTCL....
SEP 12, 2018
Microbiology
SEP 12, 2018
Researchers ID a Link Between a Bacterial Strain and Gastric Cancer
Helicobacter pylori is a bacterium that causes stomach ulcers, and can lead to gastric cancer....
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
Loading Comments...